Both in Pharmaceuticals
MapLight Therapeutics vs Opus Genetics
Over the past year MPLT returned −58.7% and IRD returned +96.8%; their daily moves had a correlation of 0.03.
MPLT −58.7% IRD +96.8%Growth of $1, one year, split-adjusted
| Metric | MPLT | IRD |
|---|---|---|
| Price | $6.71 | $4.27 |
| Market cap | $372.9M | $355.2M |
| Today | −1.47% | +8.65% |
| 1 month | −30.8% | −2.5% |
| 6 months | −76.9% | −18.8% |
| Year to date | −61.8% | +112.4% |
| 1 year | −60.3% | +99.5% |
| Revenue growth (YoY) | — | −73.8% |
| Gross margin | — | 100.0% |
| Net margin | — | −1072.6% |
| P/E (TTM) | — | — |
| Price / sales | — | 36.0× |
| Net cash | $304.7M | $53.9M |
| Dividend yield | — | — |
| Volatility (60d) | 61.1% | 93.5% |
| Short % of float | 24.6% | 21.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).